DOBAK JOHN DANIEL U S A,LOCKE KENNETH WALTER U S A
申请号：
IN10224/DELNP/2011
公开号：
IN2011DN10224A
申请日:
2011.12.23
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
Provided herein are pharmaceutical formulations, methods, and systems for the cosmetic alteration of fat deposits. Methods comprise administering a pharmaceutical formulation of a long-acting beta-2 adrenergic receptor agonist, for example, salmeterol, that is suitable for subcutaneous administration. Methods further comprise administering a pharmaceutical formulation that is suitable for subcutaneous injection comprising: (a) a lipophilic long-acting selective beta-2 adrenergic receptor agonist and/or glucocorticosteroid, or a salt, optical isomer, racemate, solvate, or polymorph thereof and (b) at least one subcutaneously acceptable inactive ingredient
